LekoskopLekoskop
HR · ES · FR · CS · IT · NL · CH · UK · PL

Europska unija — odluke Europske komisije — studeni 2026.

Ukinuta odobrenja, povlačenje serija lijekova, pisma zdravstvenim radnicima i novi lijekovi EU — svakodnevno, automatski. Zadnje ažuriranje: 16. 11. 2026. 08:55

Sve Ukinuta odobrenja8 Povlačenje serija Novi lijekovi (EU)2 Sigurnost (DHPC)1 Europska unija45
poništi

Izvori: promjene pratimo na temelju informacija Agencije za lijekove i medicinske proizvode (HALMED) — rješenja o ukidanju odobrenja, obavijesti o povlačenju serija i pisma zdravstvenim radnicima. Odluke o centralizirano odobrenim lijekovima dolaze iz registra Unije Europske komisije (oznaka EU). Nestašice i liste lijekova HZZO-a ovdje (još) nisu uključene.

12. 11. 2026.četvrtak, 12. studenoga 2026. · prije 5 dana

otvori dan ◀ ▶ 9 događaja
Novo odobrenje EU EU FREHEMGO
br. EU/1/26/2074 · FREHEMGO is indicated for routine prophylaxis of bleeding episodes in patients with haemophilia A (congenital … · Novo Nordisk A/S · denecimig
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU mRESVIA
br. EU/1/24/1849 · odobreno 22. 8. 2024. · mRESVIA is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caus… · MODERNA BIOTECH SPAIN, S.L. · Single-stranded 5' capped mRNA encoding the respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation · ATC J07BX05
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Rubraca
br. EU/1/17/1250 · odobreno 24. 5. 2018. · Rubraca is indicated as monotherapy for the maintenance treatment of adult patients with advanced (FIGO Stages… · pharmaand GmbH · rucaparib · ATC L01XK03
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Revlimid
br. EU/1/07/391 · odobreno 14. 6. 2007. · Multiple myeloma Revlimid as monotherapy is indicated for the maintenance treatment of adult patients with ne… · Bristol-Myers Squibb Pharma EEIG · Lenalidomide · ATC L04AX04
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Pandemic influenza vaccine H5N1 AstraZeneca
br. EU/1/16/1089 · odobreno 20. 5. 2016. · Pandemic influenza vaccine H5N1 AstraZeneca is indicated for active immunisation against influenza in an offic… · AstraZeneca AB · Pandemic influenza vaccine (H5N1) (live, nasal) · ATC J07BB03
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Orencia
br. EU/1/07/389 · odobreno 21. 5. 2007. · Rheumatoid arthritis ORENCIA, in combination with methotrexate, is indicated for: - the treatment of moder… · Bristol-Myers Squibb Pharma EEIG · abatacept · ATC L04AA24
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Ngenla
br. EU/1/21/1617 · odobreno 14. 2. 2022. · Ngenla is indicated for the treatment of children and adolescents from 3 years of age with growth disturbance … · Pfizer Europe MA EEIG · somatrogon · ATC H01AC08
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Fymskina
br. EU/1/24/1862 · odobreno 25. 9. 2024. · Plaque psoriasis Fymskina is indicated for the treatment of moderate to severe plaque psoriasis in adults who… · Formycon AG · ustekinumab · ATC L04AC05
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU AUGTYRO
br. EU/1/24/1883 · odobreno 13. 1. 2025. · AUGTYRO as monotherapy is indicated for the treatment of adult patients with ROS1-positive advanced non-small … · Bristol Myers Squibb Pharma EEIG · repotrectinib · ATC L01EX28
Što to znači, detalji

Učitavanje…

10. 11. 2026.utorak, 10. studenoga 2026. · prije 7 dana

otvori dan ◀ ▶ 1 događaj
Odluka Europske komisije EU Kirsty
br. EU/1/20/1506 · odobreno 5. 2. 2021. · Kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and abo… · Biosimilar Collaborations Ireland Limited · Insulin aspart · ATC A10AB05
Što to znači, detalji

Učitavanje…

6. 11. 2026.petak, 6. studenoga 2026. · prije 11 dana

otvori dan ◀ ▶ 7 događaja
Odluka Europske komisije EU Zilbrysq
br. EU/1/23/1764 · odobreno 1. 12. 2023. · Zilbrysq is indicated as an add-on to standard therapy for the treatment of generalised myasthenia gravis (gMG… · UCB Pharma S.A. · zilucoplan · ATC L04AJ06
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Sorafenib Accord
br. EU/1/22/1696 · odobreno 9. 11. 2022. · Hepatocellular carcinoma Sorafenib Accord is indicated for the treatment of hepatocellular carcinoma. Rena… · Accord Healthcare S.L.U. · sorafenib · ATC L01EX02
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Slenyto
br. EU/1/18/1318 · odobreno 20. 9. 2018. · Slenyto is indicated for: - treatment of insomnia in children and adolescents aged 2-18 years with Autism Spe… · RAD Neurim Pharmaceuticals EEC SARL · melatonin · ATC N05CH01
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Rolcya
br. EU/1/25/1958 · odobreno 17. 7. 2025. · Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal… · Sandoz GmbH · denosumab · ATC M05BX04
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Granpidam
br. EU/1/16/1137 · odobreno 14. 11. 2016. · Adults Treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II… · Accord Healthcare S.L.U. · sildenafil · ATC G04BE03
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Gohibic
br. EU/1/24/1884 · odobreno 13. 1. 2025. · Gohibic is indicated for the treatment of adult patients with SARS CoV2 induced acute respiratory distress syn… · InflaRx GmbH · vilobelimab · ATC L04AJ10
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Aybintio
br. EU/1/20/1454 · odobreno 19. 8. 2020. · Aybintio in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of adult patients … · Samsung Bioepis NL B.V. · bevacizumab · ATC L01FG01
Što to znači, detalji

Učitavanje…

4. 11. 2026.srijeda, 4. studenoga 2026. · prije 13 dana

otvori dan ◀ ▶ 2 događaja
Odluka Europske komisije EU Sogroya
br. EU/1/20/1501 · odobreno 31. 3. 2021. · Paediatric patients Sogroya is indicated for treatment of growth failure in children and adolescents in the… · Novo Nordisk A/S · somapacitan · ATC H01AC07
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Jyseleca
br. EU/1/20/1480 · odobreno 24. 9. 2020. · Rheumatoid arthritis: Jyseleca is indicated for the treatment of moderate to severe active rheumatoid arthrit… · Alfasigma S.p.A. · filgotinib · ATC L04AF04
Što to znači, detalji

Učitavanje…

3. 11. 2026.utorak, 3. studenoga 2026.

otvori dan ◀ ▶ 4 događaja
Odluka Europske komisije EU Zypadhera
br. EU/1/08/479 · odobreno 19. 11. 2008. · Maintenance treatment of adult patients with schizophrenia sufficiently stabilised during acute treatment with… · CHEPLAPHARM Registration GmbH · Olanzapine · ATC N05AH03
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Stoboclo
br. EU/1/24/1905 · odobreno 14. 2. 2025. · Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal… · Celltrion Healthcare Hungary Kft. · Denosumab · ATC M05BX04
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Krazati
br. EU/1/23/1744 · odobreno 5. 1. 2024. · Krazati as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung canc… · Bristol Myers Squibb Pharma EEIG · adagrasib · ATC L01XX77
Što to znači, detalji

Učitavanje…

Odluka Europske komisije EU Atectura Breezhaler
br. EU/1/20/1439 · odobreno 30. 5. 2020. · Atectura Breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of ag… · Novartis Europharm Limited · indacaterol / mometasone furoate · ATC R03AK14
Što to znači, detalji

Učitavanje…

Ukupno 23 događaja u ovoj kategoriji.